IGM Biosciences, Inc. logo

IGM Biosciences, Inc.

NASDAQ:IGMS

Overview | Financials
Company Name IGM Biosciences, Inc.
Symbol IGMS
Currency USD
Price 8.08
Market Cap 476,910,470
Dividend Yield 0%
52-week-range 3.81 - 17.7
Industry Biotechnology
Sector Healthcare
CEO Mr. Fred M. Schwarzer J.D.
Website https://igmbio.com

An error occurred while fetching data.

About IGM Biosciences, Inc.

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma

Related Stocks

Catalyst Pharmaceuticals, Inc. logo

Catalyst Pharmaceuticals, Inc.

CPRX

15.45 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

16.81 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.15 USD

Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc.

DCPH

25.59 USD

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

3.75 USD

Theravance Biopharma, Inc. logo

Theravance Biopharma, Inc.

TBPH

8.64 USD

Editas Medicine, Inc. logo

Editas Medicine, Inc.

EDIT

6.04 USD

Alector, Inc. logo

Alector, Inc.

ALEC

4.7 USD

Financials

Numbers are in millions USD

Numbers are in millions USD